News Search Results
Jun 20, 2025, 07:30 ET Anixa Biosciences to Host an Investor Webcast on June 26, 2025
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it will host an investor webcast presentation on June
More news about: Anixa Biosciences, Inc.
Jun 20, 2025, 02:54 ET MGI Tech Receives CE Mark for DNBSEQ-T1+ Sequencer
focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. We provide real-time, multi-omics, and a full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare, and various
More news about: MGI Tech
Jun 20, 2025, 02:21 ET BIOVAXYS ANNOUNCES AMENDED LIFE OFFERING
receive the required regulatory approvals. With regards to BioVaxys' business, there are a number of risks that could affect the development of its biotechnology products, including, without limitation, the need for additional capital to fund clinical trials, its lack of operating history, uncertainty about
More news about: BioVaxys Technology Corp.
Jun 19, 2025, 14:36 ET Biological Safety Cabinets Market to Reach USD 448.4 Million by 2032, Driven by Rising Biosafety Standards and Research Demand
B2)Class III Biological Safety CabinetsBy End-User: Research LaboratoriesPharmaceutical and Biotechnology CompaniesHospitals and Diagnostic CentersAcademic InstitutesBy Application: Drug Discovery
More news about: Credence Research Inc.
Jun 19, 2025, 14:15 ET New Study Data on Chemo-Immunotherapy Approach Using the ELIAS Cancer Immunotherapy (ECI®) to Treat Bone Cancer in Dogs Demonstrates Improved Outcomes
the study and ECI® by visiting ELIAS Animal Health at Booth 723. About ELIAS Animal Health ELIAS Animal Health is a medical biotechnology company focused on advancing a pipeline of immunotherapies, including an adoptive cell therapy and an oncolytic virotherapy, for the treatment of
More news about: ELIAS Animal Health
Jun 19, 2025, 11:52 ET Seek Common Ground, Connect the World, the 6th Qingdao Multinationals Summit Opens Today
Commerce stated that China will accelerate foreign-funded pilot projects in areas such as cloud computing and biotechnology, expand the Catalogue of Industries Encouraging Foreign Investment, and encourage policies of reinvestment, demonstrating China's
More news about: Information Office of the People's Government of Shandong Province
Jun 19, 2025, 11:41 ET Seek Common Ground, Connect the World, the 6th Qingdao Multinationals Summit Opens Today
Commerce stated that China will accelerate foreign-funded pilot projects in areas such as cloud computing and biotechnology, expand the Catalogue of Industries Encouraging Foreign Investment, and encourage policies of reinvestment, demonstrating China's
More news about: Information Office of the People's Government of Shandong Province
Jun 19, 2025, 11:20 ET Squash Rackets Market Size to Surpass USD US$ 414.40 Million by 2031, exhibiting a CAGR of 5.4% | The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jun 19, 2025, 11:15 ET FTRE INVESTOR DEADLINE: Fortrea Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
global clinical research organization ("CRO") that provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers. According to the complaint, in June 2023, Labcorp Holdings Inc. spun off Fortrea as
More news about: Robbins Geller Rudman & Dowd LLP
Jun 19, 2025, 11:13 ET Infectious Disease Testing Market Remains Dynamic Amid Post-Pandemic Shifts and New Innovations
division of Science and Medicine Group, is a leading provider of healthcare market research, delivering actionable intelligence to diagnostics, biotechnology, medical device, and pharmaceutical companies worldwide. Website: https://www.kaloramainformation.com
More news about: Kalorama Information
Jun 19, 2025, 10:50 ET Pharmaceutical Membrane Filters Market Size to Surpass USD 20.05 Billion by 2031, at 13.1% CAGR: The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jun 19, 2025, 10:30 ET Colonoscopy Devices Market Size to Surpass USD 3.36 Billion by 2031, exhibiting a CAGR of 5.7% | The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: TIP Knowledge Services Pvt. Ltd.
Jun 19, 2025, 10:30 ET Infusion Pump Market worth US$28.3 billion by 2030 with 7.4% CAGR | MarketsandMarkets™.
Baxter is a leading entity in the healthcare sector, with a strong emphasis on medical devices, pharmaceuticals, and biotechnology aimed at addressing various diseases and chronic conditions. The company's expertise spans acute and chronic dialysis therapies, sterile intravenous
More news about: MarketsandMarkets
Jun 19, 2025, 10:29 ET Biodefense Market Size worth $22.8 billion, Globally, by 2030 with 5% CAGR - Exclusive Study by The Research Insights
the United States accounting for most of its share. Federal financial support combined with established programs and sophisticated biotechnology facilities drive regional advantages. The Department of Defense (DoD), Biomedical Advanced Research and Development Authority (BARDA), and Department
More news about: The Research Insights
Jun 19, 2025, 08:03 ET RyboDyn Selected to Join Lilly Gateway Labs to Advance Next-Gen Immunotherapies Targeting the Dark Proteome
SAN DIEGO, June 19, 2025 /PRNewswire/ -- RyboDyn, Inc., a biotechnology company pioneering first-in-class immunotherapies targeting the dark proteome, today announced its selection to join Lilly Gateway Labs (LGL) in
More news about: RyboDyn
Jun 19, 2025, 01:46 ET Immuno Cure and PharmaJet Announce Collaboration to Advance a Novel HIV Therapeutic DNA Vaccine Using Needle-Free Technology in Humans
June 19, 2025 /PRNewswire/ -- Immuno Cure BioTech ("Immuno Cure"), a clinical-stage biotechnology group based in Hong Kong Science Park, is pleased to announce its upcoming collaboration with PharmaJet® to evaluate the safety and immunogenicity
More news about: Immuno Cure Holding (HK) Limited
Jun 18, 2025, 20:00 ET Brain Navi Biotechnology Co., Ltd. アメリカFDAの認可を取得
脳神経外科スマート手術ナビゲーションロボット「NaoTrac」国際的な高度医療市場へ本格進出を開始 竹北市、2025年6月19日 /PRNewswire/ -- 自身も外科医でありシリアルアントントレプレナーでもある陳階曉氏（Dr.Jerry Chen）によって設立されたBrain Navi Biotechnology Co., Ltd.（以下BN社）は、同社が独自に開発した脳神経外科ナビゲーション手術ロボット「NaoTrac」が、（2025, 5月25日）米国食品医薬品局（FDA）の510(k)認証を正式に取得したことを発表しました。
More news about: Brain Navi Biotechnology Co., Ltd.
Jun 18, 2025, 16:30 ET Nuvalent Appoints Christy Oliger to Board of Directors
of novel kinase inhibitors in 2026." Ms. Oliger brings more than 30 years of commercial and business experience in the pharmaceutical and biotechnology industry to the Nuvalent Board. Most recently, Ms. Oliger served as Senior Vice President of the Oncology Business Unit at Genentech, where she
More news about: Nuvalent, Inc.
Jun 18, 2025, 15:10 ET Caroline Trainor Joins Rubin and Rudman's Trusts and Estates Group
Rubin and Rudman serves national and international companies, including large public companies and closely held businesses; real estate developers; biotechnology, pharmaceutical and medical device makers; regulated industries, public entities and municipalities; insurance companies and their insureds; educational
More news about: Rubin and Rudman
Jun 18, 2025, 12:40 ET Polydeoxyribonudeotide (PDRN) Market to Surge with Anti-Aging & Regenerative Therapies Demand: Valuates Reports
r POLYDEOXYRIBONUDEOTIDE (PDRN) MARKET SHARE ANALYSIS Global key players of Polydeoxyribonudeotide (PDRN) include HTL Biotechnology and ReaLi Tide Biological. The top two players hold a share over 44%. China is the largest market, with
More news about: Valuates Reports
Jun 18, 2025, 12:30 ET Catalyst Clinical Research Wins the Excellence in Clinical Trial Management Award
Catalyst Clinical Research, a contract research organization (CRO), provides highly customizable solutions to the global biopharmaceutical and biotechnology industries through two established, branded solutions: Catalyst Oncology and Catalyst Flex. The company provides full-service oncology
More news about: Catalyst Clinical Research
Jun 18, 2025, 11:41 ET Gear Pump Market Size is Predicted to Reach US$ 15.40 Billion by 2031, Expanding at a CAGR of 4.9% | The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jun 18, 2025, 11:30 ET RCKT INVESTOR NOTICE: Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
[email protected]. CASE ALLEGATIONS: Rocket Pharmaceuticals operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases. The Rocket Pharmaceuticals class action lawsuit
More news about: Robbins Geller Rudman & Dowd LLP
Jun 18, 2025, 11:30 ET Truck Loading Market Size to Reach $26.0 Billion, Globally, by 2031 at 3.5% CAGR: The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jun 18, 2025, 11:00 ET Oligonucleotide Synthesis Market is expected to generate a revenue of USD 5.75 Billion by 2031, Globally, at 10.49% CAGR: Verified Market Research®
Increasing R&D in genomics and rising investment in biotech innovations are making synthetic oligos a vital tool in precision healthcare and biotechnology workflows. Key Highlights of the Report: Market Size & Forecast – In-depth analysis of current
More news about: Verified Market Research